等待开盘 06-26 09:30:00 美东时间
-0.145
-1.29%
FDA reverses its rejection of Regenxbio Navsunli, allowing the company to refile its gene therapy application.
06-22 21:23
https://subscriber.politicopro.com/article/2026/05/makarys-time-atop-fda-over-tktk-named-acting-commissioner-00916014
05-13 00:49
Replimune gets FDA CRL for RP1 melanoma therapy, disputes review process as analysts cut ratings and price targets sharply.
04-14 01:44
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gain...
04-14 00:36
Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 76.7% to $0.18 du...
04-13 20:05
HC Wainwright & Co. analyst Robert Burns downgrades Replimune Group (NASDAQ:REPL) from Buy to Sell.
04-13 18:29
Replimune awaits FDA decision on RP1 for skin cancer after initial rejection, with weak technicals and prior rejection concerns.
04-09 23:19
Replimune Group (NASDAQ:REPL) reported its Q3 earnings results on Tuesday, Febr...
02-03 21:44
Replimune Group (NASDAQ:REPL) reported quarterly losses of $(0.77) per share which beat the analyst consensus estimate of $(0.78) by 0.77 percent. This is a 2.53 percent increase over losses of $(0.79) per share from the
02-03 21:16
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining mor...
2025-11-03 21:14